-$1.15 (-0.36%)
Industry, Sector & symbol
Stock Exchange | National Stock Exchange of India |
CEO | Mr. Sanjay Surendra Shah |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Current Symbol | SAKAR.NS |
CUSIP | Y7455Q100 |
CIK | None |
Web | https://www.sakarhealthcare.com |
Phone | 91 79 2658 4655 |
Currency | INR |
Employees | 325 |
Country | IN |
Liquidity
Debt-to-Equity Ratio | 0.31 |
Payout Ratio | 0.00 |
Current Ratio | 1.12 |
Quick Ratio | 0.65 |
Cash Ratio | 0.00 |
Sales & Book Value
Annual Sales | $1.54B |
Price / Sales | 4.25 |
Cash Flow | 7.97 |
Price / Cash Flow | 40.26 |
Price / Book | 2.59 |
Price Target and Rating
Average Stock Price Forecast | $ |
High Stock Price Forecast | $ |
Low Stock Price Forecast | $ |
Forecast Upside/Downside | % |
Consensus Rating | Sell |
Rating Score(0-5) | 2 |
Research Coverage | 0 Analysts |
Profitability
EPS (Most Recent Fiscal Year) | $5.69 |
Trailing P/E Ratio | 56.25 |
PEG Ratio | 5.49 |
P/E Growth | 5.49 |
Net Income | $116.71M |
Net Margin | 7.55% |
Pretax Margin | 10.73% |
Return on Equity | 4.81% |
Return on Assets | 3.07% |
Financials Score
AltmanZ Score | 3.74 |
Piotroski Score | 6.00 |
Working Capital | 89.35M |
Total Assets | 4.04B |
Ebit | 238.32M |
Market Cap | 7B |
Total Liabilities | 1.35B |
About Sakar Healthcare Limited (NSE:SAKAR.NS) Stock
Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable SVP in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in approximately 22 therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The company also exports its products to approximately 38 countries, including Southeast Asia, Asia, Africa ... -Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.
Frequently Asked Questions
What is the current Sakar Healthcare Limited (SAKAR.NS) stock price?
Sakar Healthcare Limited(NSE:SAKAR.NS) stock price is $320.8 in the last trading session. During the trading session, SAKAR.NS stock reached the peak price of $479.0 while $279.85 was the lowest point it dropped to. The percentage change in SAKAR.NS stock occurred in the recent session was --0.36% while the dollar amount for the price change in SAKAR.NS stock was -$-1.15.
SAKAR.NS's industry and sector of operation?
The NSE listed SAKAR.NS is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
Who are the executives of SAKAR.NS?
Mr. Aarsh Sanjay Shah
| Joint MD & Executive Director
Mr. Sunil Vasantrao Marathe
| Technical Director & Whole Time Director
Mr. Dharmesh R. Thaker
| Chief Financial Officer
Mr. Sanjay Surendra Shah
| Chairman & MD
Mr. Bharat S. Soni
| Company Secretary & Compliance Officer
How many employees does SAKAR.NS have?
Number of SAKAR.NS employees currently stands at 325. SAKAR.NS operates from 406, Silver Oaks Comm. Complex, Ahmedabad, None 380007, IN.
Link for SAKAR.NS official website?
Official Website of SAKAR.NS is: https://www.sakarhealthcare.com
How do I contact SAKAR.NS?
SAKAR.NS could be contacted at phone #91 79 2658 4655 and can also be accessed through its website. SAKAR.NS operates from 406, Silver Oaks Comm. Complex, Ahmedabad, None 380007, IN.
How many shares of SAKAR.NS are traded daily?
The average number of SAKAR.NS shares traded daily for last 3 months was 31.31K.
What is the market cap of SAKAR.NS currently?
The market value of SAKAR.NS currently stands at $6.98B with its latest stock price at $320.8